We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$14.6B
AUM Growth
+$1.24B
Cap. Flow
+$998M
Cap. Flow %
6.84%
Top 10 Hldgs %
15.27%
Holding
2,202
New
241
Increased
1,177
Reduced
603
Closed
133

Sector Composition

Rank Sector Weight
1 Energy 9.2%
2 Healthcare 8.03%
3 Technology 7.82%
4 Financials 7.64%
5 Industrials 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NIHD
2176
DELISTED
NII HOLDINGS INC CL B
NIHD
-82,731
Closed -$228K

Similar funds

Raymond James & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Raymond James & Associates held 2,202 positions worth $14.6B, up 9.3% from $13.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $998M of net new capital in Q1 2014, opening 241 new positions and adding to 1,177 existing holdings. Its largest new stake was Edgewell Personal Care: 199,912 shares worth $14.9M.

By sector, the portfolio is most concentrated in Energy at 9.2% of assets, down from 9.4% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Vodafone, an estimated $33.9M trimmed.

  • Raymond James & Associates's largest Q1 2014 buy was Edgewell Personal Care: 199,912 shares worth $14.9M.
  • Raymond James & Associates added most to Verizon in Q1 2014, an estimated $31.6M increase.
  • Raymond James & Associates's biggest Q1 2014 reduction was Vodafone, cutting an estimated $33.9M.
  • Raymond James & Associates fully exited Nu Skin in Q1 2014, selling an estimated $5.53M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $14.6B portfolio in Q1 2014.
  • Raymond James & Associates opened 241 new positions and closed 133 in Q1 2014.
  • Raymond James & Associates's portfolio value rose 9.3% quarter-over-quarter to $14.6B.

Based on Raymond James & Associates's 13F filing for Q1 2014, filed 13 May 2014.